HomeAll NewsEducationTV
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Vitamin Well Secures $2.2 Billion Through Cross-Currency Loan

Created at 22 Jul · 9:56 PM1 source↑ Market-relevant
IN SHORT

Functional food and beverage company Vitamin Well has secured a $2.2 billion cross-currency loan. Private equity firm Cinven is set to become the largest shareholder, acquiring a stake from Bridgepoint, which will retain a minority holding.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$2.2 billioncross-currency loan secured by Vitamin Well
500Vitamin Well employees
40+markets where Vitamin Well products are sold
2016year Bridgepoint partnered with Vitamin Well

Who's Involved

Vitamin Well
functional food and beverage business
Cinven
international private equity firm and new lead investor
Bridgepoint
private equity firm retaining a minority stake
Christopher Bley
Partner and Co-Head of the Nordics at Bridgepoint
Johan Dahlfors
Partner and Co-Head of the Nordics at Bridgepoint
Jonas Pettersson
CEO and Co-Founder at Vitamin Well
Vitamin Well Secures $2.2 Billion Through Cross-Currency Loan

↳ Why This Matters

The substantial loan and change in lead investor signal continued confidence in Vitamin Well's growth trajectory and international expansion plans, while also highlighting evolving terms in the leveraged finance market.

Key facts

  • Vitamin Well has secured a $2.2 billion cross-currency loan.
  • Cinven is becoming the largest shareholder in Vitamin Well.
  • Bridgepoint will retain a significant minority stake.
  • The company has approximately 500 employees and operates in over 40 markets.
  • Vitamin Well's brands include Vitamin Well, NOCCO, and Barebells.

Vitamin Well, a functional food and beverage company, has secured a $2.2 billion cross-currency loan. The deal also involves private equity firm Cinven becoming the largest shareholder, acquiring a stake from Bridgepoint, which will retain a significant minority holding. Bridgepoint has been a partner to Vitamin Well since 2016, during which time the company's revenue increased twelvefold and its employee count grew from 50 to 500.

Vitamin Well, established in 2008 and headquartered in Stockholm, offers products for health-conscious consumers under brands such as Vitamin Well, NOCCO, and Barebells. These products are sold in over 40 markets globally. Cinven's investment aims to support Vitamin Well's continued growth through international expansion and product development.

In related loan documentation for Vitamin Well, lenders successfully resisted a controversial disqualified counsel restriction and the removal of high watermarking, according to sources.

Frequently asked questions

Vitamin Well is a fast-growing functional food and beverage business established in 2008, offering premium products for health-conscious and active consumers.

Cinven is becoming the new lead investor and largest shareholder, while Bridgepoint will retain a significant minority stake.

Vitamin Well has secured a $2.2 billion cross-currency loan.

Vitamin Well's portfolio includes core brands such as Vitamin Well (vitamin and mineral-enriched drinks), NOCCO (performance energy drinks), and Barebells (protein bars and shakes).

What Happens Next

01Cinven will support Vitamin Well's growth aspirations.
02Bridgepoint will continue to work with Vitamin Well and Cinven.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

Bridgepoint funds agreed to exit their investment in Vitamin Well.
Cinven will become the largest shareholder in Vitamin Well.
Bridgepoint will retain a significant minority stake in the company.
Vitamin Well has secured a $2.2 billion cross-currency loan.
Lenders successfully pushed back against a disqualified counsel restriction in Vitamin Well's loan documents.
High watermarking was removed from Vitamin Well's loan documents.

Sources

T1
Vitamin Well Raises $2.2 Billion From Cross-Currency Loan DealBloomberg
T2
Cinven Said in Talks to Buy Stake in Bridgepoint's Vitamin ...bloomberg.com
T2
US LevFin Wrap — New Trump trades and riskier deals hit US credit markets9fin.com
T2
Bridgepoint agrees sale of investment in Vitamin Wellbridgepointgroup.com

Related Stories

Aston Martin Secures $735 Million Financing Led by BlackRock-Owned HPS
22 Jul · 4:29 PM
Nestle nears sale of European water business stake to Platinum Equity
22 Jul · 1:53 PM
Lazard Hires J.P. Morgan Private Equity Dealmaker Klaus Hessberger
22 Jul · 3:31 PM
Iwoca explores sale options valued at over £1bn
22 Jul · 1:31 PM
Ryder Cup signs Stripe as worldwide partner for 2027 and 2029 events
22 Jul · 10:06 AM